Results 11 to 20 of about 6,974,500 (303)

Severe COVID-19

The University of Louisville Journal of Respiratory Infections, 2020
Introduction: There is substantial variation in the clinical characteristics and outcomes of severe coronavirus disease (COVID-19), making it difficult to do an optimal assessment of this condition.
Arpan H Chawala, Shivam Gulati, Bettina Sinanova, Jose Bordon   +3 more
doaj   +5 more sources

Expert Report for the UK Covid-19 Public Inquiry: Module 2B: Welsh Government core political and administrative decision-making in relation to the Covid-19 pandemic [PDF]

Expect Report for the UK Covid-19 Public Inquiry: Module 2B: Welsh Government core political and administrative decision-making in relation to the Covid-19 ...
Wincott, Daniel, UK Covid-19 Public Inquiry   +1 more
core   +6 more sources

Severity of the COVID‐19 pandemic in India [PDF]

Review of Development Economics, 2021
AbstractThe main objective of this study is to identify the socioeconomic, meteorological, and geographical factors associated with the severity of COVID‐19 pandemic in India. The severity is measured by the cumulative severity ratio (CSR)—the ratio of the cumulative COVID‐related deaths to the deaths in a pre‐pandemic year—its first difference and ...
Imai, Katsushi S., Kaicker, Nidhi, Gaiha, Raghav   +2 more
openaire   +2 more sources

Anakinra for severe forms of COVID-19 [PDF]

The Lancet Rheumatology, 2020
International ...
Khan, Adil Rashid, Soneja, Manish, George, Netto, Wig, Naveet   +3 more
  +10 more sources

Susceptibility to severe COVID-19 [PDF]

Science, 2020
Genetic variants and autoantibodies that suppress antiviral immunity are linked to severe COVID ...
Beck, David B., Aksentijevich, Ivona
openaire   +2 more sources

Management of Severe COVID‐19 in Pregnancy [PDF]

Case Reports in Obstetrics and Gynecology, 2020
The scarcity of data concerning pregnant patients gravely infected with severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) makes their management difficult, as most of the reported cases in the literature present mild pneumonia symptoms. The core problem is laying out evidence on coronavirus’s implications on pregnancy and delivery, as well ...
Yassamine Abourida, Houssam Rebahi, Imane Oussayeh, Hajar Chichou, Bouchra Fakhir, Abderraouf Soummani, Hicham Jalal, Fatiha Bennaoui, Nadia El Idrissi Slitine, Fadl Mrabih Rabou Maoulainine, Ahmed Rhassane El Adib, Mohamed Abdenacer Samkaoui   +11 more
openaire   +3 more sources

COVID-19 vaccination for people with disabilities [PDF]

, 2021
Internationally, people with disabilities have been disproportionately impacted by COVID-19, accounting for nearly 60% of COVID-19 deaths in the UK and overall higher mortality rates based on social, clinical, and demographic factors.
Stall, Nathan M, Brown, H, Katz, G, Bell, S, Rochon, P, Razak, Fahad, Lunsky, Y, Safar, Y, Downer, Matthew B, Brown, Hilary, Campanella, Sabrina, Cooper, Jane, Porch, W, Rotenberg, Sara, Rochon, Paula A, Downer, Mathew Bruce, Stall, N, Razak, F, Schull, M, Porch, Wendy, Bell, Sandi, Schull, Michael, Safar, Yousef, Lunsky, Yona, Katz, Gabrielle M, Cooper, J, Campanella, S   +26 more
core   +1 more source

Genetic susceptibility to severe COVID-19

Infection, Genetics and Evolution, 2023
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the etiologic agent of the coronavirus disease 2019 (COVID-19) pandemic. Clinical manifestations of the disease range from an asymptomatic condition to life-threatening events and death, with more severe courses being associated with age, male sex, and comorbidities.
Cappadona, Claudio, Rimoldi, Valeria, Paraboschi, Elvezia Maria, Asselta, Rosanna   +3 more
openaire   +2 more sources

Bangladesh: The impact of COVID-19 and food system responses

, 2021
While Bangladesh has had reactionary responses to the newer waves of COVID-19, it is projected that the country could face severe consequences if the Delta variant detected in May 2021 spreads. Since the beginning of the health crisis, CGIAR and partners
COVID-19 Hub
core   +1 more source

Efficacy and Safety of Sarilumab in Hospitalized Patients With COVID-19: A Randomized Clinical Trial [PDF]

, 2022
Background: Open-label platform trials and a prospective meta-analysis suggest efficacy of anti–IL-6R therapies in hospitalized patients with COVID-19 receiving corticosteroids.
DiCioccio, A. Thomas, Saggar, Suraj, Herman, Gary A., Sivapalasingam, Sumathi, Aberg, Judith A., Kampman, Wendy, Ferreira, Manuel A., Kosmicki, Jack A., O'Brien, Meagan P., Boyapati, Anita, Criner, Gerard, Hosain, Romana, Labriola-Tompkins, Emily, Musser, Bret J., Akinlade, Bolanle, Brown, Samuel M., Bhore, Rafia, Ng Gong, Michelle, Horowitz, Julie E., Hajizadeh, Negin, Sobieszczyk, Magdalena E., Park, William, Gulabani, Daya, Yancopoulos, George D., Mahmood, Adnan, Lederer, David J., Sperber, Steven J., Weinrich, David M., Stein, David K., Baras, Aris, Giannelou, Angeliki, Menon, Vidya, Somersan-Karakaya, Selin, Purcell, Lisa A., Nivens, Michael C., Parrino, Janie, Kowal, Bari, Waldron, Alpana, Braunstein, Ned, Criner|, Ramesh, Divya   +40 more
core   +1 more source